These results suggest that SET8 binds to PGC1α to attenuate the activity of the promoter of Keap1, which leads to high expression of Nrf2 and a high level of oxidation resistance in HCC cells. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.